Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/35394
Title: Biochemical comparison of 8 h haemodialysis and 4 h haemodiafiltration, and two dialysis membranes, in a randomized cross-over trial.
Authors: Polkinghorne K.R. ;Kerr P.G. ;Choo S.Z.
Monash Health Department(s): Nephrology
Institution: (Choo, Polkinghorne, Kerr) Department of Nephrology, Monash Health, Clayton, VIC, Australia (Polkinghorne, Kerr) Department of Medicine, Monash University, Clayton, VIC, Australia (Polkinghorne) School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Issue Date: 5-Mar-2020
Copyright year: 2019
Publisher: Blackwell Publishing
Place of publication: Australia
Publication information: Nephrology. 24 (5) (pp 542-549), 2019. Date of Publication: 01 May 2019.
Journal: Nephrology
Abstract: Aim: Extended-hours haemodialysis has long been regarded as the optimal form of dialysis for solute clearance. With emerging benefits of haemodiafiltration, we wanted to compare these two head-to-head. Method(s): In this randomized cross-over trial, we recruited existing nocturnal haemodialysis patients, who had not been hospitalized in the prior 3 months. After a baseline 8 h haemodialysis session, subjects were randomized to either 2 weeks of 8 h haemodialysis or 4 h haemodiafiltration with cross-over to the alternative treatment after a 2-week washout period. Subjects were additionally randomized to the Fresenius FX80 or Nipro Elisio in a parallel design. Blood and dialysate samples were collected at baseline and at the end of both study periods. Result(s): Twelve patients completed the study. Mean (SD) age and body mass index were 55.1 +/- 11.5 years and 36.4 +/- 10.8, respectively. Urea and creatinine reduction ratios were higher with extended-hours haemodialysis compared to haemodiafiltration (difference 14.0%, 95% CI = 10.6, 17.3; P < 0.001 and 9.1%, 95% CI = 11.0, 7.2; P < 0.001). Fibroblast growth factor 23 (FGF23) clearance was superior with haemodiafiltration (difference 20.1%, 95% CI = 8.7, 31.6; P = 0.001). No difference was seen in reduction ratios for phosphate, retinol binding protein, alpha-1-microglobulin, beta-2-microglobulin and fetuin with both modalities. Compared to Nipro Elisio, Fresenius FX80 dialyser achieved higher beta-2-microglobulin clearance (Period 1: difference 7.8%, 95% CI = 1.3, 14.4; P = 0.02, Period 2:7.5%, 95% CI = 1.0, 14.1; P = 0.02). Conclusion(s): Small solute clearance was superior with extended-hours haemodialysis while haemodiafiltration enhanced FGF23 clearance. Beta-2-microglobulin clearance was improved with Fresenius FX80 dialyser, but this difference is unlikely to be clinically significant.Copyright © 2018 Asian Pacific Society of Nephrology
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/nep.13397
PubMed URL: 29722110 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29722110]
ISSN: 1320-5358
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/35394
Type: Article
Subjects: human
adult
article
clinical article
cohort analysis
controlled study
creatinine blood level
crossover procedure
female
*hemodiafiltration
*hemodialysis
hospitalization
intermethod comparison
male
pilot study
priority journal
prospective study
randomized controlled trial
treatment duration
alpha 1 microglobulin/ec [Endogenous Compound]
beta 2 microglobulin/ec [Endogenous Compound]
creatinine/ec [Endogenous Compound]
fetuin/ec [Endogenous Compound]
fibroblast growth factor 23/ec [Endogenous Compound]
retinol binding protein/ec [Endogenous Compound]
dialysate
dialyzer
Fresenius FX80
Nipro Elisio
creatinine blood level
crossover procedure
hemodiafiltration
hemodialysis
hospitalization
intermethod comparison
pilot study
alpha 1 microglobulin
beta 2 microglobulin
creatinine
fetuin
fibroblast growth factor 23
retinol binding protein
dialysate
dialyzer
Fresenius FX80
Nipro Elisio
*hemodialysis
hospitalization
human
male
pilot study
priority journal
prospective study
randomized controlled trial
treatment duration
intermethod comparison
adult
Article
clinical article
cohort analysis
controlled study
creatinine blood level
crossover procedure
female
*hemodiafiltration
Type of Clinical Study or Trial: Randomised controlled trial
Appears in Collections:Articles

Show full item record

Page view(s)

42
checked on Aug 29, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.